Phase II Trial of Antiemetic Oral Granisetron Plus Dexamethasone for Nausea and Vomiting Caused by Crizotinib in ALK or ROS1 Fusion-Positive NSCLC

被引：0

作者：

Kawasumi, K. ^{[1
]}

Morise, M. ^{[2
]}

Kirita, K. ^{[1
]}

Saeki, K. ^{[3
]}

Kameoka, H. ^{[3
]}

Daga, H. ^{[4
]}

Miyazaki, M. ^{[5
]}

Toyozawa, R. ^{[6
]}

Uoi, M. ^{[6
]}

Harada, M. ^{[7
]}

Tamaki, S. ^{[7
]}

Takeda, M. ^{[8
]}

Fujiwara, K. ^{[9
]}

Yamanaka, T. ^{[10
]}

Goto, K. ^{[1
]}

机构：

[1] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[2] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan

[3] Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan

[4] Osaka City Gen Hosp, Osaka, Japan

[5] Nagoya Univ Hosp, Nagoya, Aichi, Japan

[6] Natl Hosp Org Kyushu Canc Ctr, Fukuoka, Japan

[7] Natl Hosp Org Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan

[8] Kindai Univ, Fac Med, Osaka, Japan

[9] Kindai Univ Hosp, Osaka, Japan

[10] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan

来源：

关键词：

crizotinib; chemotherapy induced nausea and vomiting; supportive care;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA02.04

引用

页码：S851 / S851

页数：1